BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2026 12:48:59 AM | Browse: 2 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 120320
Country South Korea
Received
2026-02-25 01:37
Peer-Review Started
2026-02-25 01:41
First Decision by Editorial Office Director
2026-04-08 08:55
Return for Revision
2026-04-08 08:55
Revised
2026-04-22 08:10
Publication Fee Transferred
Second Decision by Editor
2026-06-12 02:34
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-12 07:44
Articles in Press
2026-06-12 07:44
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-09-03 01:36
Publish the Manuscript Online
2026-09-10 00:48
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Resolved hepatitis B is associated with higher reactivation risk than chronic infection after chemoembolization for hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Dong Yun Kim, Jaehong Jeong, Jung Pyo Hong, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim and Hye Won Lee
ORCID
Author(s) ORCID Number
Dong Yun Kim http://orcid.org/0000-0002-2471-3385
Beom Kyung Kim http://orcid.org/0000-0002-5363-2496
Seung Up Kim http://orcid.org/0000-0002-9658-8050
Jun Yong Park http://orcid.org/0000-0001-6324-2224
Sang Hoon Ahn http://orcid.org/0000-0002-3629-4624
Do Young Kim http://orcid.org/0000-0002-8327-3439
Hye Won Lee http://orcid.org/0000-0002-3552-3560
Funding Agency and Grant Number
Funding Agency Grant Number
Faculty Research Grant of Yonsei University College of Medicine 6-2020-0210
Korea Health Technology R&D Project through the Korea Health Industry Development Institute RS-2025-25459146
Corresponding Author Hye Won Lee, Department of Internal Medicine, Yonsei University College of Medicine, 50, Yonsei-ro, Seodaemun-gu, Seoul 03722, South Korea. lorry-lee@yuhs.ac
Key Words Hepatitis B virus reactivation; Transarterial chemoembolization; Hepatocellular carcinoma; Resolved hepatitis B infection; Anti-hepatitis B core antibody positive
Core Tip Current international guidelines classify resolved hepatitis B virus (HBV) infection as moderate-risk for reactivation during transarterial chemoembolization, yet our study of 774 patients with confirmed HBV serostatus reveals a 21.3% reactivation rate in hepatitis B surface antigen-negative/anti-hepatitis B core antibody-positive patients, substantially exceeding the moderate-risk threshold. Resolved HBV status was the strongest independent predictor of reactivation (adjusted hazard ratio: 3.98), paradoxically conferring higher risk than chronic infection. These findings challenge existing risk classifications and support prophylactic antiviral therapy rather than monitoring alone for this vulnerable population.
Publish Date 2026-09-10 00:48
Citation

Kim DY, Jeong J, Hong JP, Lee JS, Kim MN, Kim BK, Kim SU, Park JY, Ahn SH, Kim DY, Lee HW. Resolved hepatitis B is associated with higher reactivation risk than chronic infection after chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2026; 32(39): 120320

URL https://www.wjgnet.com/1007-9327/full/v32/i39/120320.htm
DOI https://doi.org/10.3748/wjg.120320
Full Article (PDF) WJG-32-120320-with-cover.pdf
STROBE Statement 120320-STROBE-statement.pdf
Manuscript File 120320_Auto_Edited_012014.docx
Answering Reviewers 120320-answering-reviewers.pdf
Audio Core Tip 120320-audio.mp3
Biostatistics Review Certificate 120320-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 120320-conflict-of-interest-statement.pdf
Copyright License Agreement 120320-copyright-assignment.pdf
Signed Informed Consent Form(s) or Document(s) 120320-informed-consent-statement.pdf
Institutional Review Board Approval Form or Document 120320-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 120320-non-native-speakers.pdf
Supplementary Material 120320-supplementary-material.pdf
Peer-review Report 120320-peer-reviews.pdf
Scientific Misconduct Check 120320-scientific-misconduct-check.png
CrossCheck Report 120320-crosscheck-report.pdf